Headlines 

How ProMED Crowdsourced the Arrival of Covid-19 and SARS

It was about 8:30 pm on December 30, and Marjorie Pollack, a physician and epidemiologist, was working in her home office in Cobble Hill, Brooklyn. Her email pinged. In her inbox was a note from a frequent and reliable contributor to ProMED, an email list of disease alerts for which Pollack serves as deputy editor. The contributor, who speaks and reads Chinese, wanted her to know about a new post that was getting some attention on Weibo, a within-China social media network. The post said that a few hours earlier,…

Read More
Headlines 

Chloroquine May Fight Covid-19and Silicon Valleys Into It

The chatter about a promising drug to fight Covid-19 started, as chatter often does (but science does not), on Twitter. A blockchain investor named James Todaro Google doc he’d cowritten, explaining the idea. What Is the Coronavirus? Plus: How can I avoid catching it? Is Covid-19 more deadly than the flu? Our in-house Know-It-Alls answer your questions. nearly a dozen drugs to treat coronavirus are in clinical trials in China, just one—remdesivir, an antiviral that was in trials against Ebola and the coronavirus MERS—is in linked to Todaro’s Google document;…

Read More